Are We Ready to Bell The Cat?: A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes

被引：19

作者：

Nassif, Michael E. ^{[1
]}

Kosiborod, Mikhail ^{[1
]}

机构：

[1] St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA

来源：

CIRCULATION | 2018年 / 138卷 / 01期

关键词：

diabetes mellitus; type; 2; sodium-glucose transporter 2; treatment outcome;

D O I：

10.1161/CIRCULATIONAHA.117.022680

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4 / 6

页数：3

共 5 条

[1] Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project [J].

Arnold, Suzanne V. ;

Inzucchi, Silvio E. ;

Tang, Fengming ;

McGuire, Darren K. ;

Mehta, Sanjeev N. ;

Maddox, Thomas M. ;

Goyal, Abhinav ;

Sperling, Laurence S. ;

Einhorn, Daniel ;

Wong, Nathan D. ;

Khunti, Kamlesh ;

Lam, Carolyn S. P. ;

Kosiborod, Mikhail .

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (15) :1637-1645

[2] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [J].

Marso, Steven P. ;

Daniels, Gilbert H. ;

Brown-Frandsen, Kirstine ;

Kristensen, Peter ;

Mann, Johannes F. E. ;

Nauck, Michael A. ;

Nissen, Steven E. ;

Pocock, Stuart ;

Poulter, Neil R. ;

Ravn, Lasse S. ;

Steinberg, William M. ;

Stockner, Mette ;

Zinman, Bernard ;

Bergenstal, Richard M. ;

Buse, John B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) :311-322

[3] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[4] Intensive glucose control and macrovascular outcomes in type 2 diabetes [J].

Turnbull, F. M. ;

Abraira, C. ;

Anderson, R. J. ;

Byington, R. P. ;

Chalmers, J. P. ;

Duckworth, W. C. ;

Evans, G. W. ;

Gerstein, H. C. ;

Holman, R. R. ;

Moritz, T. E. ;

Neal, B. C. ;

Ninomiya, T. ;

Patel, A. A. ;

Paul, S. K. ;

Travert, F. ;

Woodward, M. .

DIABETOLOGIA, 2009, 52 (11) :2288-2298

[5] Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →